Articles From: IPOs and Transactions: September 2 - 5 to IRADIMED CORPORATION Announces Conference Call to Discuss the Status of the Recent FDA Warning Letter


2014/9/8
Last week's review of corporations and law firms NEW YORK , Sept.
Sign-up for IPOs and Transactions: September 2 - 5 investment picks
2014/9/15
Last week's review of corporations and law firms NEW YORK , Sept.
Sign-up for IPOs and Transactions: September 8 - 12 investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe investment picks
Ipsen N.A. , an affiliate of Ipsen (Euronext:IPN; ADR:IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NETs1 in the US with Priority Review investment picks
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline ® Depot ® (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Sign-up for Ipsen Announces FDA Approval of a New Delivery Device for Somatuline® Depot® (lanreotide) Injection investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced positive results from the phase III study of triptorelin pamoate 11.25 mg (Decapeptyl ® 3 months) administered subcutaneously in patients with locally advanced or metastatic prostate cancer at the European Association of Urology (EAU) 14 th Central European Meeting in Cracow, Poland (10-12 October 2014). The primary objective of the study was to assess the efficacy and safety profile of the sustained-release triptorelin pamoate 11.25 mg (Decapeptyl ® 3 months) formulation when administered by the subcutaneous route in men with locally advanced or metastatic prostate cancer.
Sign-up for Ipsen Announces Positive Results from Phase III Clinical Study of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered by Subcutaneous Route to Prostate Cancer Patients investment picks
2014/8/26
Ipsen N.A. (Euronext: IPN; ADR: IPSEY) today announced that a new supply of Increlex ® will be available starting in September 2014.
Sign-up for Ipsen Announces Second Resupply of Increlex® (mecasermin [rDNA origin] Injection) in the U.S. in 2014 investment picks
2014/8/20
Ipsen (Euronext:IPN; ADR:IPSEY) today announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A ., responsible for all commercial and medical affairs operations throughout the region.
Sign-up for Ipsen Appoints Cynthia Schwalm as President and CEO of Ipsen North America investment picks
2014/11/5
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that Donald Pearl has joined the company as Vice President of Neurology.
Sign-up for Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology investment picks
2014/9/10
Ipsen Biopharmaceuticals, Inc. , an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced key hires as the company continues to build its executive management capabilities.
Sign-up for Ipsen Biopharmaceuticals, Inc. Announces Key Medical and Commercial Hires investment picks
2014/9/27
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation at the ESMO 2014 Congress (26-30 September in Madrid) of the preliminary results of the phase II proof-of-concept clinical trial with tasquinimod in monotherapy, evaluating the compound in four advanced tumor types.
Sign-up for Ipsen Presents Preliminary Results of Exploratory Proof-of-Concept Study with Tasquinimod in Four Advanced Tumor Types at the ESMO 2014 Congress investment picks
2014/8/29
Regualtory News: The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 28 August 2014 to approve the financial statements for the first half 2014, published today.
Sign-up for Ipsen: 2014 Half-Year Results and 2014 Objectives investment picks
2014/10/29
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today reported its sales for the third quarter and first nine months of 2014.
Sign-up for Ipsen: sales in the 3rd quarter and first nine months of 2014 investment picks
Leading Companies, Universities and Laboratories Sponsor Pooled ULR Contract on IEEE 802.11n CHICAGO , Oct.
Sign-up for IPXI® Announces Multi-Party Offering for Wireless Communications Standard Essential Patents investment picks
Schubert Jonckheer & Kolbe LLP Investigates Case Against the Company's Top Executives SAN FRANCISCO , Oct.
Sign-up for IPXL Shareholder Alert: Do You Own Stock in IPXL Educational Services? investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the expansion of its portfolio of insulated-gate bipolar transistors (IGBTs) with the introduction of a family of rugged, reliable 650V devices optimized for fast switching applications including solar inverters, welding equipment, industrial motors, induction heating and uninterruptible power supplies (UPS). Ranging from 15A to 90A, the IRGP47xx family of IGBTs utilizes trench thin-wafer technology to reduce conduction and switching losses to deliver increased system efficiency.
Sign-up for IR Expands Portfolio of Ultra-fast Trench IGBTs with 650V Devices for Welding, Solar, Industrial Motors, Induction Heating and UPS Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the expansion of its StrongIRFET™ MOSFET portfolio to include 75V devices for a wide variety of industrial applications including power tools, Light Electric Vehicle (LEV) inverters, DC motor drives, Li-Ion battery pack protection, Hot-Swap and Switched Mode Power Supply (SMPS) secondary-side synchronous rectification.
Sign-up for IR Expands StrongIRFET™ Family with New 75V MOSFETs Featuring Ultra-low Rds(on) for Industrial Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the expansion of its StrongIRFET™ MOSFET portfolio to include 75V devices for a wide variety of industrial applications including power tools, Light Electric Vehicle (LEV) inverters, DC motor drives, Li-Ion battery pack protection, Hot-Swap and Switched Mode Power Supply (SMPS) secondary-side synchronous rectification.
Sign-up for IR Expands StrongIRFET™ Family with New Surface Mount 75V MOSFETs Featuring Ultra-low Rds(on) for Industrial Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the introduction of the IR66xx series of high performance 600V ultra-fast Trench-gate Field Stop insulated-gate bipolar transistors (IGBTs). The new rugged, reliable family of devices features extremely low conduction and switching losses optimized for welding applications.
Sign-up for IR Introduces IR66xx Series of High Performance 600V Ultra-fast Trench IGBTs Optimized for Welding Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today introduced a comprehensive family of IGBT modules for high power industrial applications including motor drive inverters, switch mode power supplies (SMPS), uninterruptible power supplies (UPS), solar inverters and welding.
Sign-up for IR Introduces New Family of IGBT Modules for High Power Industrial Applications investment picks
International Rectifier, IR ® (NYSE:IRF), a world leader in power management technology, today introduced the automotive-qualified AUIRB24427S high current dual low-side driver IC for Switched Mode Power Supply (SMPS) applications used in Hybrid Electrical Vehicles (HEV), Electric Vehicles (EV), and high power industrial converters.
Sign-up for IR Introduces Robust Automotive-Qualified AUIRB24427S Dual Low-side Driver IC for Switched Mode Power Supply (SMPS) Applications investment picks
International Rectifier , IR ® (NYSE: IRF), a world leader in power management technology, today announced the company's CHiL ® Digital PWM Controllers and Integrated PowIRstage ® solution has been named a Top 10 Power Product of 2014 by Electronic Products China (EPC). EPC’s editors and panel of experts determine the top power products based on criteria that includes a significant advancement in a technology or its application, innovative design, and substantial achievement in price/performance. IR’s new digital controllers meet Intel VR12 and VR12.5 specifications, and support multiphase designs from 1 to 8 phases operating 1 to 2 loops.
Sign-up for IR's CHiL® Digital PWM Controller and Integrated PowIRStage® Named a Top 10 Power Product by Electronic Products China investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced the introduction of the AUIRFN8459 and AUIRFN8458 40V automotive-qualified COOLiRFET™ power MOSFETs that offer benchmark on-state resistance (RDS(on)) for automotive applications requiring compact size and high current performance including pump motor control and automotive body control.
Sign-up for IR’s Automotive-Qualified 40V 5x6mm Dual PQFN COOLiRFET™s Deliver Benchmark Performance for Low Power Motor Applications investment picks
International Rectifier, IR ® (NYSE: IRF), a world leader in power management technology, today announced that the company’s Generation 8 (Gen8) 1200V Insulated Gate Bipolar Transistor (IGBT) technology platform and IR3847 SupIRBuck ® high current integrated voltage regulator have been named winners of the prestigious 2014 China Annual Creativity in Electronics (ACE) Awards.
Sign-up for IR’s Gen8 IGBT Technology Platform and IR3847 SupIRBuck® Named 2014 China ACE Awards Winners investment picks
2010/02/22
The best and worst candidates for this maneuver, and details on how it works.
Sign-up for IRA Conversion Fact Sheet investment picks
2011/02/15
We highlight the best and worst candidates for this maneuver, and details on how it works.
Sign-up for IRA Conversion Fact Sheet investment picks
2009/08/27
Low investment balances, relaxed income limits make it worthy of consideration.
Sign-up for IRA Conversion: The Planning Opportunity of the Decade? investment picks
WINTER SPRINGS, Fla., Sept.
Sign-up for IRADIMED CORPORATION Announces Conference Call to Discuss the Status of the Recent FDA Warning Letter investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: IPOs and Transactions: September 2 - 5 to IRADIMED CORPORATION Announces Conference Call to Discuss the Status of the Recent FDA Warning Letter
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent